329
Participants
Start Date
September 21, 2015
Primary Completion Date
January 22, 2016
Study Completion Date
July 20, 2016
Ad26.ZEBOV-Batch #1
Ad26.ZEBOV - Batch #1, live, replication incompetent vaccine, sterile suspension of 0.5 milliliter (mL) intramuscular (IM) injection of 5\*10\^10 viral particles on Day 1
Ad26.ZEBOV-Batch #2
Ad26.ZEBOV - Batch #2, live, replication incompetent vaccine, sterile suspension of 0.5 milliliter (mL) intramuscular (IM) injection of 5\*10\^10 viral particles on Day 1
Ad26.ZEBOV-Batch #3
Ad26.ZEBOV - Batch #3, live, replication incompetent vaccine, sterile suspension of 0.5 milliliter (mL) intramuscular (IM) injection of 5\*10\^10 viral particles on Day 1
MVA-BN-Filo
MVA-BN-Filo- live replication incompetent vaccine, 0.5 mL IM injection of 1\*10\^8 Infectious Unit \[Inf. U.\] once on Day 57.
Placebo
One 0.5 ml IM injection of 0.9% saline once on Day 1 and Day 57.
Huntsville
San Diego
Melbourne
Peoria
Mishawaka
Rockville
Crucell Holland BV
INDUSTRY